Imprint Wealth’s ResMed RMD Stock Holding History

Imprint Wealth’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.6K	Hold	47	–	–	0.05%	118
2025 Q4	$11.3K	Sell	47 -47	-50%	-$12K	0.05%	138
2025 Q3	$25.7K	Buy	+94	New	+$25.7K	0.08%	107

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Imprint Wealth's RMD Position: Q1 2026 in Review

Imprint Wealth held its ResMed (RMD) position steady in Q1 2026 at 47 shares worth $10.6K. The position accounts for 0.05% of the portfolio, ranked #118.

Imprint Wealth first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $25.7K in Q3 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Imprint Wealth held 47 shares of ResMed worth $10.6K as of Q1 2026.
Imprint Wealth left its ResMed share count unchanged in Q1 2026.
ResMed made up 0.05% of Imprint Wealth's portfolio in Q1 2026, its #118 holding.
Imprint Wealth first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
Imprint Wealth's ResMed position peaked at $25.7K in Q3 2025.
939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Imprint Wealth's 13F filing for Q1 2026, filed 15 May 2026.